amantadine hydrochloride

Generic: amantadine hydrochloride

Labeler: atlantic biologicals corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amantadine hydrochloride
Generic Name amantadine hydrochloride
Labeler atlantic biologicals corp.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

amantadine hydrochloride 50 mg/5mL

Manufacturer
ATLANTIC BIOLOGICALS CORP.

Identifiers & Regulatory

Product NDC 17856-0093
Product ID 17856-0093_3b3e31b5-ced7-b373-e063-6294a90a16b2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075060
Listing Expiration 2026-12-31
Marketing Start 1998-12-24

Pharmacologic Class

Classes
influenza a m2 protein inhibitor [epc] m2 protein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 178560093
Hyphenated Format 17856-0093

Supplemental Identifiers

RxCUI
849385
UNII
M6Q1EO9TD0

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amantadine hydrochloride (source: ndc)
Generic Name amantadine hydrochloride (source: ndc)
Application Number ANDA075060 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/5mL
source: ndc
Packaging
  • HOW SUPPLIED NDC:17856-0093-3 in a CUP, UNIT-DOSE of 5 SOLUTIONS Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. KEEP TIGHTLY CLOSED Dispense in a tight container as defined in the USP, with a child-resistant closure (as required).
  • AMANTADINE HYDROCHLORIDE SOLUTION image description
source: label

Packages (0)

No package records.

Ingredients (1)

amantadine hydrochloride (50 mg/5mL)

Linked Drug Pages (1)

Amantadine Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3b3e31b5-ced7-b373-e063-6294a90a16b2", "openfda": {"unii": ["M6Q1EO9TD0"], "rxcui": ["849385"], "spl_set_id": ["97d6bd4a-31ca-4b33-8353-a536835ef1e1"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [], "brand_name": "Amantadine Hydrochloride", "product_id": "17856-0093_3b3e31b5-ced7-b373-e063-6294a90a16b2", "dosage_form": "SOLUTION", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "17856-0093", "generic_name": "AMANTADINE HYDROCHLORIDE", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amantadine Hydrochloride", "active_ingredients": [{"name": "AMANTADINE HYDROCHLORIDE", "strength": "50 mg/5mL"}], "application_number": "ANDA075060", "marketing_category": "ANDA", "marketing_start_date": "19981224", "listing_expiration_date": "20261231"}